-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QrUTrkuugCGIGfylad1nX+BxkMuL/5vreN5WiIvyB0vMxhTrDfTHt5L7XDbHrio6 ZUC3/ozJfTf+GkarKEA0vg== 0000950135-00-002142.txt : 20000414 0000950135-00-002142.hdr.sgml : 20000414 ACCESSION NUMBER: 0000950135-00-002142 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALKERMES INC CENTRAL INDEX KEY: 0000874663 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232472830 STATE OF INCORPORATION: PA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-31354 FILM NUMBER: 600542 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139-4136 BUSINESS PHONE: 6174940171 424B3 1 ALKERMES, INC. 1 Prospectus Supplement No. 5 Filed pursuant to Rule 424(b)(3) to Prospectus dated March 6, 2000 Registration No. 333-31354 ALKERMES, INC. $250,000,000 3 3/4% CONVERTIBLE SUBORDINATED NOTES DUE 2007 1,845,018 SHARES OF COMMON STOCK This prospectus supplement supplements the information contained in the prospectus of Alkermes, Inc. dated March 6, 2000, as supplemented by Prospectus Supplement No. 1 dated March 10, 2000, Prospectus Supplement No. 2 dated March 17, 2000, Prospectus Supplement No. 3 dated March 24, 2000 and Prospectus Supplement No. 4 dated April 5, 2000, relating to the potential resale from time to time of the 3 3/4% Convertible Subordinated Notes due 2007 of Alkermes and the resale of shares of common stock of Alkermes issuable upon conversion of the notes. This prospectus supplement is not complete without, and may not be delivered or utilized except in connection with, the prospectus, including any amendments or supplements thereto. The following table supplements the information set forth in the prospectus under the caption "Selling Securityholders" with respect to the selling securityholders and the respective principal amount of notes which are beneficially owned and may be sold by each selling securityholder, and the number of shares of common stock that may be sold by the selling securityholders pursuant to this prospectus, as amended or supplemented:
Number of Shares of Common Stock Issued Upon Conversion Principal Amount of Notes of the Notes that May be Beneficially Owned and Offered (2) Name of Selling Securityholder (1) Offered Credit Suisse First Boston Corporation $3,000,000 22,140
(1) The information set forth herein is as of April 13, 2000 and will be updated as required. (2) Assumes conversion of the full principal amount of the notes held by such holder at the initial conversion price of $135.50 per share of common stock. THE DATE OF THIS PROSPECTUS SUPPLEMENT IS APRIL 13, 2000 -----END PRIVACY-ENHANCED MESSAGE-----